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hmSEEKER: Identiﬁcation of hmSILAC Doublets in
MaxQuant Output Data
Enrico Massignani, Alessandro Cuomo, Daniele Musiani, SriGanesh Jammula,
Giulio Pavesi,* and Tiziana Bonaldi*
Heavy methyl Stable Isotope Labeling with Amino acids in Cell culture
(hmSILAC) is a metabolic labeling strategy employed in proteomics to
increase the conﬁdence of global identiﬁcation of methylated peptides by MS.
However, to this day, the automatic and robust identiﬁcation of heavy and
light peak doublets from MS-raw data of hmSILAC experiments is a
challenging task, for which the choice of computational methods is very
limited. Here, hmSEEKER, a software designed to work downstream of a
MaxQuant analysis for in-depth search of MS peak pairs that correspond to
light and heavy methyl-peptide within MaxQuant-generated tables is
described with good sensitivity and speciﬁcity. The software is written in Perl,
and its code and user manual are freely available at Bitbucket
(https://bit.ly/2scCT9u).
Protein methylation is a posttranslational modiﬁcation (PTM)
consisting in the addition of one or more methyl-groups to argi-
nine and lysine residues of a protein. Lysine can be mono-, di-,
or tri-methylated, while arginine can be mono- or di-methylated.
Arginine di-methylation can, in turn, be either symmetrical or
asymmetrical. While the functional implication of histone lysine
and arginine methylation in the regulation of gene expression
is well established, recent evidence revealed that this PTM
is widespread at the proteome level, a notion that expands
its regulatory potential well beyond chromatin structure and
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transcriptional regulation.[1] These
discoveries are the results of sev-
eral technical improvements in the
ﬁeld of MS-based proteomics, an an-
alytical strategy widely adopted to
investigate PTMs at the global proteome
level.
Nevertheless, identifying in vivo pro-
tein methylations by MS is still chal-
lenging and error-prone, mainly because
various amino acid substitutions (e.g.,
glycine to alanine) and chemical methyl-
esteriﬁcation of aspartic and glutamic
acid (occurring when protein samples are
exposed to methanol or ethanol) are iso-
baric to methylation. Thus, the use of
orthogonal validation methods to reduce
False Discovery Rates (FDRs) has been recommended.[2]
A reliable strategy for the identiﬁcation of in vivo methylated
peptides is called heavy methyl Stable Isotope Labeling with
Amino acids in Cell culture (hmSILAC),[3] a metabolic label-
ing strategy achieved by growing cells in the presence of natu-
ral methionine (Light, L) or 13CD3-methionine (Heavy, H). Cells
convert methionine into S-adenosyl-methionine, the sole donor
of methyl-groups used by protein methyltransferases to mod-
ify their substrates. Hence, methyl-groups added to the protein
backbone through an enzymatic reaction will exist in either the
light or the heavy form. Given a 1:1 mix of light- and heavy- la-
beled cells, followed by protein extraction, digestion, and pep-
tide separation, the analysis by LC–MS/MS permits the identi-
ﬁcation of peptides bearing in vivo enzymatically driven methy-
lations that in theMS readout will form pairs of H-L peaks, diﬀer-
ing for a speciﬁc mass value. Conversely, false positive methyla-
tions do not produce H-L doublets, since they exist only in the
light form. The hmSILAC strategy has been employed in nu-
merous large-scaleMS-based analyses of protein-methylation,[4,5]
leading to a signiﬁcant reduction of FDRs when compared to
approaches not relying on hmSILAC or similar strategies (e.g.,
iMethyl-SILAC).[5]
At the moment, there is however a lack of bioinformatic
tools speciﬁcally designed for the identiﬁcation ofmethyl-peptide
pairs from hmSILAC data. Among the few methods available,
PyQuant is a MS data quantiﬁcation package that supports sev-
eral labeling strategies, both chemical and metabolic, such as
SILAC, iTRAQ, and Neucode.[6] The package is highly ﬂexible
and is capable of processing hmSILAC data, although this spe-
ciﬁc labeling needs to be explicitly conﬁgured by the user.[7] An-
other suitable software package is MethylQuant, which is specif-
ically designed to reconstruct and quantify hmSILAC doublets
directly from raw MS1 spectra.[8]
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We present here hmSEEKER, a novel tool that allows a
fast and reliable identiﬁcation of hmSILAC H-L doublets by
processing proteomic data outputs generated by MaxQuant.[9]
The latter choice was motivated by the fact that MaxQuant is
a widely used software suite designed for the accurate identi-
ﬁcation and quantitation of peptides, since it includes several
functions like MS1 peak detection, integration of diﬀerent mass
measurements to increase mass accuracy, peptide identiﬁcation
based on their MS/MS spectra through the Andromeda search
engine,[10] and quantitation of peptides and proteins. hmSEEKER
thus permits a straightforward integration of hmSILAC with any
other type of high-resolution quantitative proteomics data pro-
cessed via MaxQuant (e.g., standard SILAC or Label Free), for
orthogonal, high-conﬁdence validation of methyl-sites.
The hmSEEKER software package is written in Perl (version
5.24.0) and is compatible with MaxQuant 1.5.8.3 and subse-
quent releases. The input consists of the “msms.txt” and “allPep-
tides.txt” ﬁles generated by MaxQuant, plus a protein sequence
collection in FASTA format, to permit the mapping of the pep-
tides to the respective sequence. The main output produced
by hmSEEKER consists of the list of all the peptide doublets
identiﬁed. It also returns a list of methyl-peptides for which a
light/heavy counterpart was not retrieved (i.e., putative false pos-
itive methylations), for manual inspection by users. The software
workﬂow is composed of three main steps (Figure 1A), detailed
as follows:
Input Reading and Filtering
Information associated with each peptide and MS1 peak is ex-
tracted from the “msms” and “allPeptides” ﬁles. All methyl-
peptides that 1) derive from contaminants, 2) have charge lower
than 2, or 3) carry simultaneously heavy and light modiﬁca-
tions are discarded. The tool also discards by default the methyl-
peptides with 1) an Andromeda peptide score <25, 2) a delta
score <12, or 3) a Localization Probability (LcPrb) of the methyl-
site<0.75. These input ﬁltering parameters can be howevermod-
iﬁed by users. Peptides are then assigned to the two H and L
classes, and the expected delta mass is calculated as the mass
shift between one light and one heavy methyl-group, multiplied
by the number of methionines and methyl-groups carried by the
peptide. This step leads to the generation of two tables: a “Peptide
Index”, containing information about all peptides that were frag-
mented by MS/MS and identiﬁed, and a “Peak Index”, including
information on all MS1 peaks that were detected, but not neces-
sarily identiﬁed by MS/MS.
Doublets Search
To identify hmSILAC doublets, hmSEEKER ﬁrst associates each
peptide in the Peptide Index with the corresponding MS1 peak
in the Peak Index, then searches for peak pairs comparing peak
charges and m/z ratios, and by computing for each pair the re-
tention time diﬀerence (RT) and Mass Error (ME), deﬁned as:
Mass Error = 106 ×
(
m/zL +m/zshift
m/zH
− 1
)
(1)
wherem/zH andm/zL are them/z ratios of theH and L objects,
respectively, and m/zshift is the expected m/z diﬀerence between
the H and L forms of the peptide. The underlying assumption is
that the two isotopic counterparts of a peptide co-elute, undergo
the same ionization process, and diﬀer only for the presence of H
or L methyl-groups. Thus, hmSEEKER can identify peptide pairs
at theMS1 level, even if one of the two counterparts is notMS/MS
fragmented, without requiring to directly parse the raw MS data.
To be considered a true doublet, a pair of peaks must satisfy all
the following conditions:
1) m/zH > m/zL,
2) ChargeH = ChargeL,
3) | RTH – RTL | < RT threshold (default = 0.5 min),
4) |ME| < ME threshold (default = 2 ppm),
5) | Log2(H/L ratio) | < Log2Ratio threshold (default = 1).
After this step, hmSEEKER produces a list containing all the
identiﬁed doublets.
Output Reﬁnement
For the doublets search step, hmSEEKER uses the values corre-
sponding to charge,ME, RT, andH/L ratio of the peaks. However,
the input also contains the peptide sequences derived from the
Andromeda peptide search. This additional information is used
by hmSEEKER after the search to deﬁne four classes of doublets:
 ”Matched”: This class includes doublets in which the two pep-
tides are identical, allowing for site-speciﬁc calling of themod-
iﬁcation.
 “Mismatched”: This class consists of H-L pairs in which the
peptides share the same amino acid sequence, but the modiﬁ-
cation is assigned to diﬀerent sites. These doublets are reason-
ably true, yet MaxQuant could not pinpoint the modiﬁcation
on one of the two counterparts. The score and LcPrb values
reported in the output can suggest which of the positional iso-
forms of themethyl-peptide is themost likely to be true.When
both H and L peptides have similar scores, users may wish to
directly check the MS/MS spectra via MaxQuant.
 “Putative False Positive (FP)”: This class contains pairs in
which two diﬀerent amino acid sequences have been assigned
to theH and L counterparts. These doublets are excluded from
the ﬁnal output.
 “Rescued”: This class contains the doublets in which only one
counterpart of the pair was identiﬁed. These doublets can
be further classiﬁed as “L only” or “H only”, depending on
the channel that was identiﬁed by MS/MS. We generally con-
sider “H only” pairs to be more reliable, because heavy methyl
groups can only derive from in vivo enzymatic methylation.
Rescued doublets expand the number of annotated methyl-
peptides beyond those where both the H and L counterparts
were fragmented by MS and identiﬁed during the database
search; yet, such methyl-peptide pairs are in principle less re-
liable than theMatched andMismatched ones. Hence, we also
estimated an FDR associated to them (see below).
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Figure 1. A) The three-step workﬂow of hmSEEKER. I) Input Reading and ﬁltering: The “msms” and “allpeptides” ﬁles from MaxQuant are ﬁltered to
remove low conﬁdence methyl-peptides and contaminants. Data are then summarized by two indexes: one includes information on objects that were
fragmented by MS/MS and thus were identiﬁed as peptides (Peptide Index), while the second contains information from all objects detected as MS1
peaks (Peak Index). II) Doublets Search: Each peptide in the Peptide Index is associated to its corresponding peak in the Peak Index, then its counterpart
is searched. Since the doublet search is performed at the MS1 peak level, it is possible to ﬁnd a counterpart even if the latter is not fragmented in MS2.
In this case hmSEEKER retrieves a ‘Rescued’ doublet. If both counterparts have been identiﬁed, a ‘Matched’ doublet is reported. III) Output Reﬁnement:
All doublets identiﬁed are listed in a “Redundant” table. Starting from this table, hmSEEKER also generates a “Non-Redundant” table, which includes
only the highest-scoring, non-redundant doublets. B) Workﬂow of the experiment carried out to generate the methyl-proteome on which hmSEEKER was
tested. I) Ovarian cancer cells SK-OV-3 were grown in media containing either light (Met-0) or heavy (Met-4) methionine. II) Upon full incorporation of
the isotopically labeled amino acids, cells were harvested and mixed in 1:1 proportion. Trypsin was used to digest in solution the proteins into peptides.
III) Peptides were then subjected to an aﬃnity enrichment step using pan-methyl-R-antibodies, LC–MS/MS aquisition was carried out on a Q Exactive
Orbitrap mass spectrometer. IV) Raw ﬁles were processed using MaxQuant to identify methylated peptides. V) Finally, MaxQuant output was processed
with hmSEEKER. Putative true positive methyl-peptides are detected as pairs of peaks separated by a speciﬁc delta mass, which reﬂects the methylation
state of the peptide (each methyl group introduces a 4.0222 Da shift). See also Supporting Information.
Finally, the software performs a step of redundancy reduction
of the output, where doublets associated to the same methyl-
peptide are ranked according to their class and total Andromeda
score, and for eachmodiﬁed peptide only the top-ranking doublet
is retained.
hmSEEKER is controlled from the command line through a
conﬁguration ﬁle, in which the user can explicitly deﬁne any
of the input ﬁltering and the doublet search parameters. If any
of these parameters is not deﬁned the conﬁguration ﬁle, its
default value will be employed. For the doublet search step, the
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ME, RT, and Log2Ratio default values have been optimized
empirically, by using a dataset generated in house from the
MS-analysis of immuno-enriched methyl-peptides from an in-
solution tryptic digestion of SK-OV-3 whole cell extract on a Q Ex-
active instrument, as detailed in Figure 1B and in the Supporting
Information. The MS raw data were processed by MaxQuant and
the output dataset was initially analyzed using permissive ME
and RT threshold values of 25 ppm and 5 min, respectively,
and no Log2Ratio cut-oﬀs. Once a ﬁrst list of hmSILAC doublets
was generated by the tool, we calculated mean (µ) and SD () of
their log2-transformed H/L ratio distribution. These values were
then employed to distinguish reliable assignments from putative
false positives. In fact, under the hypothesis that the two H and L
samples were grown in the same condition and mixed in 1:1 pro-
portion, the H/L ratio of genuine hmSILAC doublets is expected
be close to 1, while false IDs will deviate from this value. Thus,
we deﬁned as High Conﬁdence (HC) the doublets with a ratio
within the µ ±  range and as Low Conﬁdence (LC) those with
ratios exceeding this range (Figure 2A).
We then progressively reﬁned the cut-oﬀs to retain the major-
ity of the HC doublets and ﬁlter out LC doublets. This led us to
deﬁne 2 ppm and 0.5 min as the ME and RT default values
(Figure 2B,C; see also Supporting Information).
To further assess speciﬁcity and sensitivity of hmSEEKER, we
focused on the methionine-containing peptides included in the
test dataset. The rationale is that, since we are labeling cells with
heavy methionine, peptides containing this amino acid will gen-
erate doublets similar tomethylated peptides. In parallel, we built
a dataset of “True Negatives”, by considering peptides that do not
contain methionine (hence, should not generate a doublet) and
randomly assigning to them one type of methylation (i.e. mono-,
di-, or tri-methylation, in either light or heavy form). From these
two datasets, we sampled 5000 and 20 000 peptide-spectrum
matches corresponding to 2136 and 13 767 non-redundant pep-
tides, respectively. In this way, we reproduced the 80% FDR that
has been observed for methyl-peptide-spectrum matches when
the results of a target–decoy peptide search are ﬁltered in or-
der to obtain a global FDR of 1%.[2] We analyzed this dataset
with hmSEEKER using the default parameters previously de-
scribed. hmSEEKER identiﬁed a doublet for 2656 methionine-
containing peptides out of 5000, corresponding to a sensitivity of
53.12%, and only 22 falsemethyl-peptides out of 20 000, resulting
in a speciﬁcity of 99.89% (Figure 2D). Of the 2656 methionine-
containing peptides, 2314 were identiﬁed as Matched doublets
and 342 as Rescued, while all 22 “false positives” were in the
Rescued class (Matched doublets FDR = 0%; Rescued doublets
FDR = 22/364 = 6.04%, Figure 2D). We however observed that
these false positives had a broader H/L peptide-pair ratio distri-
bution with respect to methionine-containing ones (Figure 2E).
This observation led us to include an additional cut-oﬀ thresh-
old, set to 1, for the Log2Ratio parameter. This cut-oﬀ reduced by
64% the number of identiﬁcations in the “true negative” subset
of peptides, but did not aﬀect the methionine-containing ones
(Figure 2F), reducing the FDR of Rescued doublets from 6.04%
to 2.34% (Figure 2F). The downside of using the doublet Ratio as
possible ﬁltering criterion is that it is not applicable in a straight-
forward way to hmSILAC experiments where the mixing ratio is
not 1:1.
These parameters were further conﬁrmed by processing two
additional hmSILAC methyl-proteomes acquired in leukemic
NB4 cells (Supporting Information). In fact, we observed that the
HC doublets were reproducibly found inside the deﬁned cut-oﬀs,
in spite of small diﬀerences in the LC–MS/MS run.
By applying these cut-oﬀ parameters to the same dataset used
for their estimation, we retrieved 646 non-redundant methyl-
peptide doublets of which 440 (68%) are identiﬁed as Matched
doublets, 44 (7%) asMismatched doublets, and 162 (25%) as Res-
cued doublets.
To benchmark the performance of hmSEEKER, we compared
our results with those obtained by re-processing the same dataset
with MethylQuant (version 1.0). To ensure that the two analyses
were truly comparable, we applied the 2-ppm and 0.5-min cut-
oﬀ values to the search and also manually removed low-scoring
peptides and peptides with mixed labeling from the input for
MethylQuant, which mimics the initial ﬁltering operated by hm-
SEEKER. MethylQuant returned 609 non-redundant doublets,
of which 69 (11%) were classiﬁed as ‘Very High Conﬁdence’,
154 (25%) as ‘High Conﬁdence’ and 386 (63%) as ‘Low Conﬁ-
dence’. We found 469 non-redundant doublets (70%) in common
between the methods (Figure 3A; Figure S3, Supporting Infor-
mation). Of the 140 doublets uniquely found by MethylQuant,
110 (79%) are Low Conﬁdence, whereas 98 doublets out of the
177 (55%) uniquely identiﬁed by our tool are Matched (Fig-
ure 3B). Through further analysis, we also found that hmSEEKER
shows a mild bias toward peptides with two positive charges,
1 or 2 missed cleavages and a higher Andromeda score, which
might explain the diﬀerences in the results (Supporting Infor-
mation). All analyses were performed on a Dell Precision T7600
workstation with 32 GB of RAM and two 2.40 GHz processors.
The run time of MaxQuant, which generated the input for both
tools was  3 days, whereas the run times for hmSEEKER and
MethylQuant were 4 min and 15 h, respectively. In fact, hm-
SEEKER takes advantage of MaxQuant tabular output and does
not need to parse the raw data on its own. Therefore, once the
database search is completed, a list of putatively true methyl-
peptides can be generated almost immediately and data can be
quickly reprocessed. Overall, this comparison suggests that our
strategy of parsingMaxQuant output tables performs comparably
to the more computationally intensive algorithm MethylQuant,
and conﬁrms the high quality of the doublets found by our
tool.
In conclusion, hmSEEKER can identify in vivo methyl-
peptides by analyzing hmSILAC data with a low rate of false pos-
itive doublets. However, since false positives fall in the Rescued
doublets category, it is advisable to perform a two-step analysis, in
which two diﬀerent set of parameters, a broad one (i.e., RT < 1
min, ME < 8 ppm, Log2Ratio < 1.5) and a stringent one (i.e.,
the default parameters), are applied consecutively to the same
dataset. The ﬁnal output could thus include theMatched andMis-
matched doublets from the broad analysis (which has higher sen-
sitivity) and the Rescued doublets only from the stringent one.
While the dependency on MaxQuant can be seen as a constraint,
it can also represent an advantage, sinceMaxQuant is widely used
for the analysis of quantitative proteomics data, which can be
more easily integrated with the hmSEEKER results for methyl-
peptides orthogonal validation. Hence, we deem hmSEEKER
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Figure 2. Optimization of hmSEEKER parameters. A) Distribution of H/L peptide ratios for ‘Matched’ doublets (purple) and the rest of the population
(white). We deﬁne as ‘High conﬁdence’ (HC) peptides in the µ ±  range calculated for the Matched doublets, and as ‘Low conﬁdence’ the rest of the
population. B) Distribution of mass errors in the HC (pink) and LC (cyan) doublets sub-populations. C) Distribution of RT in the HC (pink) and LC
(cyan) doublets sub-populations. D) Results of the analysis performed on 5000 methionine-containing peptides and 20 000 false methyl-peptides. E)
Boxplot representation of the H/L doublet ratio distributions of methionine-containing peptides (cyan and pink) and false positives (green). F) Results
of the second analysis, performed on the same dataset, in which we ﬁltered doublets based on their H/L ratio, in addition to ME andRT.
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Figure 3. Comparison between the output of hmSEEKER and MethylQuant. A) Overlap between the methyl-peptide doublets identiﬁed as putative true.
B) Left: Pie-chart showing the percentages of Matched, Mismatched, and Rescued doublets among the 177 peptides that are unique for hmSEEKER.
Right: Pie-chart showing the percentages of Very High, High, and Low conﬁdence doublets among the 140 peptides that are unique for MethylQuant.
a highly useful tool for the annotation of high-conﬁdence
methyl-proteomes.
Supporting Information
Supporting Information is available from the Wiley Online Library or from
the author.
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